同仁堂：参苓白术散获加拿大产品注册许可

Core Viewpoint - Tong Ren Tang announced that its subsidiary, Tong Ren Tang Pharmaceutical Factory, received a product license (Class III) from Health Canada for its product Shen Ling Bai Zhu San, which is used to alleviate symptoms of spleen and stomach weakness [1] Group 1 - The product is a powder formulation aimed at addressing specific health issues [1] - The total investment in the product's research and development has reached approximately 2.29 million yuan [1] - The product must still undergo Canadian production quality system certification and other approvals before it can be sold in Canada, indicating uncertainty in the commercialization process [1] Group 2 - The approval of the product is not expected to have a significant impact on the company's recent operating performance [1]